In-depth Analysis and Data-driven Insights on the Impact of COVID-19 Included in this Global Clinical Nutrition Market Report
The clinical nutrition market is expected to grow at a CAGR of 8.96% during 2021-2026.
Clinical nutrition remains significantly important to ensure better survival outcomes for patients suffering from critical conditions arising from COVID-19. The increasing number of malnutrition cases is surging the industry growth. Clinical nutrition is a highly regulated market and is generally prescribed for intake during medical supervision across various settings such as hospitals, clinics, and home care facilities.
The following factors are likely to contribute to the growth of the clinical nutrition market during the forecast period: • Rising Incidence of Chronic and Metabolic Disorders • Increasing Preference of Enteral Over Parenteral • High Demand for Clinical Nutrition Among Cancer Patients • Growing Popularity of Home-Based Healthcare
The report considers the present scenario of the clinical nutrition market and its market dynamics for the period 2021?2026. It covers a detailed overview of several market growth enablers, restraints, and trends. The study covers both the demand and supply sides of the market. It also profiles and analyzes leading companies and several other prominent companies operating in the market.
CLINICAL NUTRITION MARKET SEGMENTATION The global clinical nutrition market research report includes a detailed segmentation by route of administration, age group, product type, application, distributional channels, end-users, geography. Focusing on health and wellness, aging well, and disease prevention by consumers, healthcare providers are demanding preventive clinical nutrition products and are experiencing rapid growth. Vendors are offering the product in dessert, yogurt, soup, and savory-style and as powders to grab customers’ attention. The key players are investing in research activities to formulate a nutritional supplement that provides nutritional benefits to patients suffering from certain medical conditions.
Global brands such as Abbott, Nestle, Nutricia, and Fresenius Kabi offer parenteral, enteral, and oral nutrition products for infants. The percentage of infants suffering from lactose intolerance is incredibly high and accounts for 71% of the population. The market has also been experiencing high demand owing to the heavy ad campaigns. The increasing prevalence of malnutrition among children is primarily driving the demand for clinical nutrition among children.
Latin America and APAC are expected to witness high traction for semi-solid powder products in the industry. Most standard clinical nutrition products are powder-based as they offer 100% micro and macronutrient requirements. Players are observing the highest level of adoption of clinical nutrition in physical stores such as supermarkets, hypermarkets, and other e-commerce websites due to the flexibility offered in packaging techniques.
In recent years, the syndrome of metabolic disorders is becoming much more common in the United States. About 37% of adult Americans are estimated to have metabolic disorders thereby, surging the demand for clinical nutrition across the globe. Major innovations and advancements in the fields of nutrition have led to rapid growth in the industry over the last decade. The developing Asian countries are becoming a focal point for significant players in the market.
The distribution of clinical nutrition products is highly significant, requiring research activities to understand the most effective and safe channel. An ideal distribution mix consisting of a considerable share of each delivery mode is regarded as the most successful strategy. Major retail channels such as Walmart, Costco, Walgreens, Sainsbury’s, Morrisons serve as the primary sources of sales in the western countries.
The rising incidence of malnutrition among hospitalized patients drives the demand for oral, enteral, and parenteral nutritional products across the globe. Vendors are arranging training sessions on equipment and feed for hospital-based healthcare professionals and patients to increase the sales of clinical nutrition. Brands such as Abbott and B. Braun offering ready-to-drink nutrition products for patients suffering from chronic diseases that are easy to consume, and flavorful products are likely to gain greater consumer attention.
Segmentation by Route of Administration • Oral • Enteral • Parenteral
Segmentation by Age Group • Infant & Toddler • Child & Teenager • Adult • Geriatric
Segmentation by Product Type • Powder • Liquid • Semi-Solid
Segmentation by Application • Malnutrition • Metabolic Disorders • Gastrointestinal Disorders • Cancer • Others
INSIGHTS BY GEOGRAPHY The proportion of cancer deaths in Asia is about 58.3% higher than the cancer incidence rate. The prevalence of chronic diseases is increasing the demand for clinical nutrition products in the region. The rapid rise of the e-commerce industry in the Asia Pacific is likely to remain at the forefront of the rapid growth of the online sale of nutritional products in the Asia Pacific. A large base of the population and the presence of high medical needs are expected to create new growth avenues for the market in the region.
Segmentation by Geography • APAC o China o Japan o South Korea o Australia o India • North America o US o Canada • Europe o Germany o UK o France o Spain • Latin America o Brazil o Mexico • Middle East & Africa o Saudi Arabia o UAE
COMPETITIVE LANDSCAPE The global clinical nutrition market is becoming highly consolidated, with a rising number of mergers and acquisitions occurring globally. Due to the possibility of incremental growth, the non-traditional players are expected to venture into the clinical nutritional supplement market during the forecast period. The global market is highly competitive with the presence of significant vendors. Abbott Laboratories, Baxter International, B. Braun, Danone, and Nestle Health Science are the major players. Due to the higher level of fragmentation, most players engage in mergers and acquisitions to overcome the competitive edge across the industry.
Key Vendors: • Abbott • Baxter • B. Braun • Danone • Nestle Health Science
Other Prominent Vendors: • Ajinomoto Cambrooke • American Regent • AnazaoHealth • Avadel Pharmaceutical • BASF SE • Exela Pharma Science • Fresenius Kabi • Grifols • ICU Medical • Lonzo • Mead Johnson & Company • Meiji Holdings Company • Otsuka Pharmaceutical Company • Perrigo Company • Reckitt Benckiser • Sanofi • Sichuan Kelun Pharmaceutical • Stepen Company
KEY QUESTIONS ANSWERED: 1. How big is the clinical nutrition market? 2. What is the U.S. clinical nutrition market growth? 3. Which segment has the highest growth rate in the global clinical nutrition market? 4. Which are the top companies holding the highest share in the market? 5. What are the key trends in the medical nutrition market report?
Our reports have been used by over 10K customers, including:
The global Micropump market is expected to reach US$ 5,172.86 million in 2028 from as estimated value of US$ 1,553.01 million in 2021. The market is likely to grow with a CAGR of 18.8% from 2021-2028. The growth of the market is due to increasing demand for micropumps in medical device industry, and improved accuracy compared to traditional...
The Peptide Therapeutics Market is valued at approximately USD 28,510.60 million in 2020 and is expected to witness a revenue of USD 51,360.30 million in 2026, with a CAGR of 9.66% over the forecast period (2021-2026). Novel peptides are being developed and repurposed as therapeutics for the treatment of COVID-19. Globally, researchers...
The global large volume parenteral (lvp) market is projected to expand at a CAGR of 6.1% by 2025. Rising number of surgeries, need for a faster route of drug administration, growing preference for single dose administration of vaccines and drugs, and increase in local manufacturing is expected to drive the market for LVP. Increasing...
The Asia Pacific the pharmaceutical drug delivery market is anticipated to reach US$ 4,73,700.1 Mn by 2027 from US$ 2,77,589.9 Mn in 2019. The market is projected to grow at a CAGR of 7.1% during 2019-2027. The growth of the pharmaceutical drug delivery market in this region is primarily attributed to the increasing shortage of medicines...
The pharmaceutical drug delivery market was valued at US$ 1,403,082.9 million in 2019 and is projected to reach US$ 2,296,170.9 million by 2027; it is expected to grow at a CAGR of 6.6% from 2020 to 2027. Factors driving the pharmaceutical drug delivery market include the growing prevalence of infectious and chronic diseases, and rising R&D...
The global superdisintegrants market is projected to reach US$ 659.17 Mn in 2027 from US$ 369.56 Mn in 2019. The market is projected to grow with a CAGR of 7.6% from 2020-2027. Driving factors include growing adoption of orally disintegrating drugs, increasing acceptability of generic drugs. However, the risk high cost associated with manufacturing...
The global superdisintegrants market is projected to grow at a CAGR of 7.9%. The superdisintegrants market is expected to reach USD 536.5 million by 2023 from an estimated USD 366.4 million in 2018, at a CAGR of 7.9%. The increasing adoption of orally disintegrating tablets, growing generics market, and emergence of new superdisintegrants...
You can change your Cookie Settings at any time but parts of our site will not function correctly without them.